DK1218378T3 - Tert.-butyl-(7-methylimidazo[1,2-a]pyridin-3-yl) aminderivater - Google Patents

Tert.-butyl-(7-methylimidazo[1,2-a]pyridin-3-yl) aminderivater

Info

Publication number: DK1218378T3
Authority: DK; Denmark
Prior art keywords: methylimidazo; pyridin; tert; butyl; amine derivatives
Prior art date: 1999-10-08

Application number

DK00969439T

Other languages

Danish (da)

English (en)

Inventor

Corinna Maul

Bernd Sundermann

Hagen-Heinrich Hennies

Johannes Schneider

Matthias Gerlach

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-08

Filing date

2000-10-06

Publication date

2003-07-21

2000-10-06 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2003-07-21 Application granted granted Critical

2003-07-21 Publication of DK1218378T3 publication Critical patent/DK1218378T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Psychology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DK00969439T 1999-10-08 2000-10-06 Tert.-butyl-(7-methylimidazo[1,2-a]pyridin-3-yl) aminderivater DK1218378T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19948434A DE19948434A1 (de)	1999-10-08	1999-10-08	Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
PCT/EP2000/009791 WO2001027109A2 (fr)	1999-10-08	2000-10-06	Derives de tert.-butyl-(methyl-imidazo[1,2-a]pyridine-3-yl)amine

Publications (1)

Publication Number	Publication Date
DK1218378T3 true DK1218378T3 (da)	2003-07-21

Family

ID=7924888

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00969439T DK1218378T3 (da)	1999-10-08	2000-10-06	Tert.-butyl-(7-methylimidazo[1,2-a]pyridin-3-yl) aminderivater

Country Status (28)

Country	Link
US (1)	US6703404B2 (fr)
EP (1)	EP1218378B1 (fr)
JP (1)	JP2003511450A (fr)
KR (1)	KR100793619B1 (fr)
CN (1)	CN1208336C (fr)
AR (2)	AR025959A1 (fr)
AT (1)	ATE238304T1 (fr)
AU (2)	AU7419900A (fr)
BR (1)	BR0014827A (fr)
CA (1)	CA2386804A1 (fr)
CO (2)	CO5210861A1 (fr)
CZ (1)	CZ20021241A3 (fr)
DE (2)	DE19948434A1 (fr)
DK (1)	DK1218378T3 (fr)
ES (1)	ES2198355T3 (fr)
HK (1)	HK1047749B (fr)
HU (1)	HUP0203545A3 (fr)
IL (3)	IL148997A0 (fr)
MX (1)	MXPA02003546A (fr)
NO (1)	NO20021564L (fr)
NZ (1)	NZ518438A (fr)
PE (2)	PE20010632A1 (fr)
PL (1)	PL355109A1 (fr)
PT (1)	PT1218378E (fr)
RU (1)	RU2002110281A (fr)
SK (1)	SK4622002A3 (fr)
WO (2)	WO2001027119A2 (fr)
ZA (2)	ZA200203579B (fr)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6083966A (en)	1998-08-31	2000-07-04	University Of Florida	Thiazoline acid derivatives
AU774956B2 (en)	1998-09-21	2004-07-15	Trustees Of Columbia University In The City Of New York, The	Antimalarial agents
WO2001076694A1 (fr)	2000-04-10	2001-10-18	Merck & Co., Inc.	Inhibiteurs de la prenyl-proteine transferase
DE10043845A1 (de) *	2000-09-06	2002-03-14	Gruenenthal Gmbh	Verfahren zur Messung der Aktivität der NO-Synthase
DE10050663A1 (de) *	2000-10-13	2002-04-18	Gruenenthal Gmbh	Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
WO2002048146A2 (fr) *	2000-12-13	2002-06-20	Basf Aktiengesellschaft	Utilisation d'imidazoazines substituees, nouvelles imidazoazines, procede permettant de les produire et agents les contenant
DE10117184A1 (de) *	2001-04-05	2002-10-17	Gruenenthal Gmbh	Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen
DE10117183A1 (de) *	2001-04-05	2002-10-10	Gruenenthal Gmbh	Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel
DE10132726A1 (de) *	2001-07-05	2003-02-27	Gruenenthal Gmbh	Verwendung von substituierten gamma-Lactonverbindungen als Arzneimittel
IL163940A0 (en)	2002-03-13	2005-12-18	Euro Celtique Sa	Aryl substituted pyrimidines and the use thereof
KR20050008691A (ko)	2002-04-19	2005-01-21	셀룰러 지노믹스 아이엔씨	이미다조[1,2-ａ]피라진-8-일 아민, 그의 제조방법 및사용방법
US20050197435A1 (en) *	2002-06-14	2005-09-08	Dotson Darin L.	Polymer additive compositions for bimolecular nucleation in thermoplastics
US7312341B2 (en)	2002-09-09	2007-12-25	Cgi Pharmaceuticals, Inc.	6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof
DE10246890A1 (de) *	2002-10-08	2004-04-22	Grünenthal GmbH	Substituierte C-Imidazo[1,2-alpyridin-3-yl-methylamine
WO2004058755A2 (fr) *	2002-12-24	2004-07-15	Biofocus Plc	Bibliotheques de composes
US7189723B2 (en)	2003-02-10	2007-03-13	Cgi Pharmaceuticals, Inc.	Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity
US7405295B2 (en)	2003-06-04	2008-07-29	Cgi Pharmaceuticals, Inc.	Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
US7393848B2 (en)	2003-06-30	2008-07-01	Cgi Pharmaceuticals, Inc.	Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
US7259164B2 (en)	2003-08-11	2007-08-21	Cgi Pharmaceuticals, Inc.	Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity
AU2003270473A1 (en)	2003-09-09	2005-04-27	University Of Florida	Desferrithiocin derivatives and their use as iron chelators
DE102004021716A1 (de) *	2004-04-30	2005-12-01	Grünenthal GmbH	Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen
DE102004044884A1 (de) *	2004-09-14	2006-05-24	Grünenthal GmbH	Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen
CA2581454A1 (fr)	2004-09-23	2006-03-30	Reddy Us Therapeutics, Inc.	Nouveaux composes de pyrimidine, leur procede de preparation, et compositions les contenant
CN101189216B (zh)	2005-04-04	2011-10-19	佛罗里达大学研究基金会	Desferrithiocin聚醚类似物
DE102005016547A1 (de) *	2005-04-08	2006-10-12	Grünenthal GmbH	Substituierte 5,6,7,8-Tetrahydro-imidazo(1,2-a)pyridin-2-ylamin-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
US7777040B2 (en)	2005-05-03	2010-08-17	Cgi Pharmaceuticals, Inc.	Certain substituted ureas, as modulators of kinase activity
MX2007014510A (es)	2005-05-20	2008-02-05	Array Biopharma Inc	Compuestos inhibidores de raf y metodos de uso de los mismos.
US8093401B2 (en)	2005-08-04	2012-01-10	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
EP2468752A1 (fr)	2005-08-04	2012-06-27	Sirtris Pharmaceuticals, Inc.	Dérivés de thiazolopyridine comme modulateurs de sirtuine
US8088928B2 (en)	2005-08-04	2012-01-03	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
US7855289B2 (en)	2005-08-04	2010-12-21	Sirtris Pharmaceuticals, Inc.	Sirtuin modulating compounds
US7709468B2 (en)	2005-09-02	2010-05-04	Abbott Laboratories	Imidazo based heterocycles
PT2495016T (pt)	2005-12-23	2019-12-16	Ariad Pharma Inc	Compostos de heteroarilo bicíclicos
DE102006011574A1 (de)	2006-03-10	2007-10-31	Grünenthal GmbH	Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln
PL2001892T3 (pl)	2006-03-17	2013-09-30	Ambit Biosciences Corp	Imidazolotiazolowe związki do leczenia chorób proliferacyjnych
WO2008115433A1 (fr)	2007-03-15	2008-09-25	University Of Florida	Analogues de polyéther de desferrithiocine
WO2008134553A1 (fr) *	2007-04-26	2008-11-06	Xenon Pharmaceuticals Inc.	Procédés de traitement de maladies associées aux canaux sodiques au moyen de composés bicycliques
GB0708188D0 (en) *	2007-04-27	2007-06-06	Merck Sharp & Dohme	Therapeutic compounds
CL2008001822A1 (es)	2007-06-20	2009-03-13	Sirtris Pharmaceuticals Inc	Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras.
CL2008001821A1 (es)	2007-06-20	2009-03-13	Sirtris Pharmaceuticals Inc	Compuestos derivados de imidazo[2,1-b]-tiazol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de diabetes, sindrome metabolico, resistencia a la insulina, entre otras.
DE102007040336A1 (de) *	2007-08-27	2009-03-05	Johann Wolfgang Goethe-Universität Frankfurt am Main	Neue Inhibitoren der 5-Lipoxygenase und deren Verwendungen
KR20150104231A (ko)	2007-09-19	2015-09-14	암비트 바이오사이언시즈 코포레이션	Ｎ-(5-ｔｅｒｔ-부틸-이속사졸-3-일)-Ｎ''-[4-[7-(2-모르폴린-4-일-에톡시)이미다조[2,1-Ｂ][1,3]벤조티아졸-2-일]페닐]우레아를 포함하는 고체 형태, 그의 조성물 및 그의 용도
AU2009215191A1 (en)	2008-02-13	2009-08-20	Gilead Connecticut, Inc.	6-aryl-imidaz0[l, 2-a] pyrazine derivatives, method of making, and method of use thereof
PT2266990E (pt) *	2008-04-15	2012-12-27	Eisai R&D Man Co Ltd	Composto de 3-fenilpirazolo[5,1-b]tiazole
CN102216298B (zh) *	2008-09-16	2014-04-16	Csir公司	作为hiv-1逆转录酶抑制剂的咪唑并吡啶和咪唑并嘧啶
JP5567587B2 (ja)	2008-12-08	2014-08-06	ギリアードコネチカット，インコーポレイテッド	イミダゾピラジンＳｙｋ阻害剤
NZ593460A (en)	2008-12-08	2013-11-29	Gilead Connecticut Inc	Imidazopyrazine syk inhibitors
US8450321B2 (en)	2008-12-08	2013-05-28	Gilead Connecticut, Inc.	6-(1H-indazol-6-yl)-N-[4-(morpholin-4-yl)phenyl]imidazo-[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
MY160006A (en)	2008-12-19	2017-02-15	Sirtris Pharmaceuticals Inc	Thiazolopyridine sirtuin modulating compounds
AR078521A1 (es) *	2009-10-08	2011-11-16	Eisai R&D Man Co Ltd	Compuesto pirazolotiazol
JP5938352B2 (ja)	2010-03-11	2016-06-22	ギリアードコネチカット，インコーポレイテッド	イミダゾピリジンｓｙｋ阻害剤
EP3620161A1 (fr)	2011-12-16	2020-03-11	University of Florida Research Foundation, Inc.	Utilisation d'analogues de 4'-desferrithiocine
WO2013163244A1 (fr)	2012-04-26	2013-10-31	Bristol-Myers Squibb Company	Dérivés d'imidazothiadiazole utilisés en tant qu'inhibiteurs des récepteurs activés par la protéase 4 (par4) pour traiter l'agrégation plaquettaire
LT2841437T (lt)	2012-04-26	2017-09-11	Bristol-Myers Squibb Company	Imidazotiadiazolo ir imidazopirazino dariniai, kaip proteazės aktyvuotų receptorių 4 (par4) inhibitoriai, skirti trombocitų agregacijos gydymui
JP6101343B2 (ja)	2012-04-26	2017-03-22	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	血小板凝集を治療するためのプロテアーゼ活性化受容体４（ｐａｒ４）阻害剤としてのイミダゾチアジアゾールおよびイミダゾピリダジン誘導体
RU2015118985A (ru) *	2012-11-14	2017-01-10	Ф. Хоффманн-Ля Рош Аг	Производные имидазопиридина
JP6153667B2 (ja)	2013-07-30	2017-06-28	ギリアードコネチカット，インコーポレイテッド	Ｓｋｙ阻害剤の製剤
ES2822285T3 (es)	2013-07-30	2021-04-30	Kronos Bio Inc	Polimorfo de inhibidores de SYK
EP3071201A4 (fr)	2013-11-22	2017-04-26	University of Florida Research Foundation, Inc.	Analogues de la desferrithiocine et leurs utilisations
EP3076976B1 (fr)	2013-12-04	2020-09-02	Gilead Sciences, Inc.	Méthode de traitement du cancer
US9290505B2 (en)	2013-12-23	2016-03-22	Gilead Sciences, Inc.	Substituted imidazo[1,2-a]pyrazines as Syk inhibitors
UY35898A (es)	2013-12-23	2015-07-31	Gilead Sciences Inc	?compuestos inhibidores de syk y composiciones que los comprenden?.
RS59534B1 (sr)	2014-02-13	2019-12-31	Incyte Corp	Ciklopropilamini kao lsd1 inhibitori
PH12020552066A1 (en)	2014-02-13	2022-05-11	Incyte Corp	Cyclopropylamines as lsd1 inhibitors
US9527835B2 (en)	2014-02-13	2016-12-27	Incyte Corporation	Cyclopropylamines as LSD1 inhibitors
ES2672797T3 (es)	2014-02-13	2018-06-18	Incyte Corporation	Ciclopropilaminas como inhibidores de LSD1
US9598419B1 (en)	2014-06-24	2017-03-21	Universite De Montreal	Imidazotriazine and imidazodiazine compounds
US9617279B1 (en)	2014-06-24	2017-04-11	Bristol-Myers Squibb Company	Imidazooxadiazole compounds
TWI687419B (zh)	2014-07-10	2020-03-11	美商英塞特公司	作為ｌｓｄ１抑制劑之咪唑并吡啶及咪唑并吡嗪
WO2016007736A1 (fr)	2014-07-10	2016-01-14	Incyte Corporation	Imidazopyrazines en tant qu'inhibiteurs de lsd1
US9758523B2 (en)	2014-07-10	2017-09-12	Incyte Corporation	Triazolopyridines and triazolopyrazines as LSD1 inhibitors
WO2016007722A1 (fr)	2014-07-10	2016-01-14	Incyte Corporation	Triazolopyridines et triazolopyrazines utilisables comme inhibiteurs de lsd1
NZ726365A (en)	2014-07-14	2018-06-29	Gilead Sciences Inc	Combinations for treating cancers
EP3626720A1 (fr)	2015-04-03	2020-03-25	Incyte Corporation	Composés hétérocycliques utilisés en tant qu'inhibiteurs de lsd1
WO2016176343A1 (fr)	2015-04-27	2016-11-03	University Of Florida Research Foundation, Incorporated	Agents chélateurs métalliques programmés métaboliquement et leurs utilisations
MX389824B (es)	2015-08-12	2025-03-20	Incyte Holdings Corp	Sales de un inhibidor de dimetilasa 1 especifica para lisina (lsd1).
IL262488B (en)	2016-04-22	2022-08-01	Incyte Corp	lsdi inhibitor formulations
US11098043B2 (en) *	2017-07-14	2021-08-24	University Of Massachusetts	Certain imidazopyridines as cyclic AMP response element binding (CREB) binding protein (CBP) inhibitors and uses thereof
WO2019040298A1 (fr)	2017-08-25	2019-02-28	Gilead Sciences, Inc.	Polymorphes inhibiteurs de syk
AU2018346331B2 (en) *	2017-10-04	2023-08-24	Dana-Farber Cancer Institute, Inc.	Small molecule inhibition of transcription factor SALL4 and uses thereof
US10968200B2 (en)	2018-08-31	2021-04-06	Incyte Corporation	Salts of an LSD1 inhibitor and processes for preparing the same
MX2021010131A (es)	2019-02-22	2021-11-18	Kronos Bio Inc	Formas sólidas de pirazinas condensadas a manera de inhibidores de syk.
WO2024220541A1 (fr) *	2023-04-18	2024-10-24	Kallyope, Inc.	Modulateurs de nk3 et leurs utilisations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3489755A (en) *	1966-08-03	1970-01-13	Pfizer & Co C	Imidazo (1,2-b) pyridazines
FR2463774A1 (fr) *	1979-08-21	1981-02-27	Yamanouchi Pharma Co Ltd	Derives du 2-phenylimidazo(2,1-b)benzothiazole
DE3269604D1 (en) *	1981-06-26	1986-04-10	Schering Corp	Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
EP0266890A1 (fr) *	1986-10-07	1988-05-11	Yamanouchi Pharmaceutical Co. Ltd.	Dérivés d'imidazopyridine, leur production et compositions pharmaceutiques les contenant
FR2638161B1 (fr) *	1988-10-24	1991-01-11	Centre Nat Rech Scient	Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
JPH08333258A (ja) *	1994-12-14	1996-12-17	Japan Tobacco Inc	チアジン又はチアゼピン誘導体及びそれら化合物を含有してなる一酸化窒素合成酵素阻害剤
GB9506188D0 (en) *	1995-03-27	1995-05-17	Fujisawa Pharmaceutical Co	Amidine derivatives
US5908842A (en) *	1995-12-08	1999-06-01	Merck & Co., Inc.	Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
AU3783497A (en) *	1996-08-09	1998-03-06	Yamanouchi Pharmaceutical Co., Ltd.	Metabotropic glutamate receptor agonists
AUPP278498A0 (en) *	1998-04-03	1998-04-30	Australian Nuclear Science & Technology Organisation	Peripheral benzodiazepine receptor binding agents

1999
- 1999-10-08 DE DE19948434A patent/DE19948434A1/de not_active Withdrawn
2000
- 2000-09-18 IL IL14899700A patent/IL148997A0/xx not_active IP Right Cessation
- 2000-09-18 AU AU74199/00A patent/AU7419900A/en not_active Abandoned
- 2000-09-18 WO PCT/EP2000/009098 patent/WO2001027119A2/fr not_active Ceased
- 2000-10-02 CO CO00074640A patent/CO5210861A1/es not_active Application Discontinuation
- 2000-10-05 AR ARP000105250A patent/AR025959A1/es not_active Application Discontinuation
- 2000-10-05 AR ARP000105251A patent/AR025960A1/es not_active Application Discontinuation
- 2000-10-06 PT PT00969439T patent/PT1218378E/pt unknown
- 2000-10-06 CZ CZ20021241A patent/CZ20021241A3/cs unknown
- 2000-10-06 CA CA002386804A patent/CA2386804A1/fr not_active Abandoned
- 2000-10-06 HK HK02109385.2A patent/HK1047749B/zh not_active IP Right Cessation
- 2000-10-06 DK DK00969439T patent/DK1218378T3/da active
- 2000-10-06 AT AT00969439T patent/ATE238304T1/de active
- 2000-10-06 RU RU2002110281/04A patent/RU2002110281A/ru not_active Application Discontinuation
- 2000-10-06 IL IL14899900A patent/IL148999A0/xx active IP Right Grant
- 2000-10-06 WO PCT/EP2000/009791 patent/WO2001027109A2/fr not_active Ceased
- 2000-10-06 JP JP2001530327A patent/JP2003511450A/ja active Pending
- 2000-10-06 MX MXPA02003546A patent/MXPA02003546A/es active IP Right Grant
- 2000-10-06 BR BR0014827-0A patent/BR0014827A/pt not_active IP Right Cessation
- 2000-10-06 CO CO00076179A patent/CO5251429A1/es not_active Application Discontinuation
- 2000-10-06 SK SK462-2002A patent/SK4622002A3/sk unknown
- 2000-10-06 AU AU79153/00A patent/AU780526B2/en not_active Ceased
- 2000-10-06 NZ NZ518438A patent/NZ518438A/en not_active IP Right Cessation
- 2000-10-06 CN CNB008167079A patent/CN1208336C/zh not_active Expired - Fee Related
- 2000-10-06 PE PE2000001063A patent/PE20010632A1/es not_active Application Discontinuation
- 2000-10-06 KR KR1020027004518A patent/KR100793619B1/ko not_active Expired - Fee Related
- 2000-10-06 ES ES00969439T patent/ES2198355T3/es not_active Expired - Lifetime
- 2000-10-06 PL PL00355109A patent/PL355109A1/xx not_active IP Right Cessation
- 2000-10-06 PE PE2000001062A patent/PE20010706A1/es not_active Application Discontinuation
- 2000-10-06 EP EP00969439A patent/EP1218378B1/fr not_active Expired - Lifetime
- 2000-10-06 DE DE50001911T patent/DE50001911D1/de not_active Expired - Lifetime
- 2000-10-06 HU HU0203545A patent/HUP0203545A3/hu unknown
2002
- 2002-04-03 NO NO20021564A patent/NO20021564L/no not_active Application Discontinuation
- 2002-04-04 IL IL148999A patent/IL148999A/en not_active IP Right Cessation
- 2002-04-08 US US10/117,339 patent/US6703404B2/en not_active Expired - Fee Related
- 2002-05-06 ZA ZA200203579A patent/ZA200203579B/xx unknown
- 2002-05-06 ZA ZA200203581A patent/ZA200203581B/xx unknown

Also Published As

Publication number	Publication date
WO2001027109A3 (fr)	2001-09-20
IL148999A0 (en)	2002-11-10
IL148999A (en)	2007-03-08
AR025960A1 (es)	2002-12-26
CN1208336C (zh)	2005-06-29
CA2386804A1 (fr)	2001-04-19
US6703404B2 (en)	2004-03-09
NO20021564L (no)	2002-06-04
RU2002110281A (ru)	2003-12-20
IL148997A0 (en)	2002-11-10
PE20010706A1 (es)	2001-08-13
ATE238304T1 (de)	2003-05-15
CO5210861A1 (es)	2002-10-30
AU7915300A (en)	2001-04-23
AU780526B2 (en)	2005-03-24
HUP0203545A2 (hu)	2003-02-28
ES2198355T3 (es)	2004-02-01
HUP0203545A3 (en)	2004-07-28
DE19948434A1 (de)	2001-06-07
HK1047749A1 (en)	2003-03-07
CN1407983A (zh)	2003-04-02
CZ20021241A3 (cs)	2002-08-14
KR20020069003A (ko)	2002-08-28
CO5251429A1 (es)	2003-02-28
PL355109A1 (en)	2004-04-05
US20030022914A1 (en)	2003-01-30
DE50001911D1 (de)	2003-05-28
WO2001027109A2 (fr)	2001-04-19
KR100793619B1 (ko)	2008-01-11
WO2001027119A3 (fr)	2001-10-11
EP1218378B1 (fr)	2003-04-23
JP2003511450A (ja)	2003-03-25
PT1218378E (pt)	2003-09-30
MXPA02003546A (es)	2002-09-18
AR025959A1 (es)	2002-12-26
HK1047749B (zh)	2003-08-22
PE20010632A1 (es)	2001-07-07
AU7419900A (en)	2001-04-23
EP1218378A2 (fr)	2002-07-03
NZ518438A (en)	2004-08-27
ZA200203581B (en)	2004-02-25
WO2001027119A2 (fr)	2001-04-19
SK4622002A3 (en)	2002-09-10
NO20021564D0 (no)	2002-04-03
BR0014827A (pt)	2003-07-08
ZA200203579B (en)	2003-10-29

Publication	Publication Date	Title
DK1218378T3 (da)	2003-07-21	Tert.-butyl-(7-methylimidazo[1,2-a]pyridin-3-yl) aminderivater
NO20020687D0 (no)	2002-02-11	3(5)-ureidopyrazolderivater, fremgangsmåte for fremstilling av disse og deres anvendelse som antitumormidler
NO20020684L (no)	2002-04-03	3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler
NO20012057D0 (no)	2001-04-26	2-amino-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler
ATE251625T1 (de)	2003-10-15	8-phenyl-6,9-dihydro-(1,2,4)triazolo(3,4-i)puri - 5-on derivate
NO20015477L (no)	2002-01-11	4,5,6,7-tetrahydroindazolderivater som antitumormidler
PL369531A1 (en)	2005-05-02	1,8-naphthyridine derivatives as antidiabetics
IS6320A (is)	2002-03-21	Pýrazóló [4,3-d] pýrimidín afleiður
NO20012058L (no)	2001-06-28	2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler
AU7556800A (en)	2001-05-10	Amine derivatives
AU4808300A (en)	2000-11-17	9h-pyrimido(4,5-b)indole derivatives: crf1 specific ligands
IL155974A0 (en)	2003-12-23	Novel pyridine-substituted pyrazolopyridine derivatives
DK1470124T3 (da)	2006-04-18	2-(Pyridin-2-yl amino)-pyrido[2,3]pyrimidin-7-oner
ZA200306341B (en)	2004-11-15	Imidazo (1,2-a)-pyridine derivatives as mGluR5 antagonists.
NO20002217D0 (no)	2000-04-28	Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
TR199800085A3 (tr)	1998-08-21	8-Sübstitüye edilmis-1,3,8-triaza- spiro(4,5)dekan-4-on türevleri.
PT1210349E (pt)	2003-06-30	Pirazolo-¬4,3-d\|-pirimidinas
NO20016404D0 (no)	2001-12-28	Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
IL140326A0 (en)	2002-02-10	Protein c derivatives
ZA200005185B (en)	2001-06-18	Indole-2,3-Dione-3-Oxime derivatives for therapeutic use.
GB0012376D0 (en)	2000-07-12	3,4,5-tricyanophenyl derivatives
DK1124810T3 (da)	2005-08-22	2-amino-thiazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som antitumormidler
PL352760A1 (en)	2003-09-08	Oxathiepino[6,5-b
ES1043557Y (es)	2000-06-01	Bolso perfeccionado.
SI1198453T1 (en)	2003-10-31	N-(indolcarbonyl-)piperazin derivatives